Metraipolis › archive › dc_ddc457922cb3

Lenalidomide ameliorates cognitive impairment via putative AChE inhibition: an in silico and in vivo study in a scopolamine-induced cognitive impairment model — Europe PMC PMID:42177211

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42177211
DOI
10.1038/s41598-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-01T09:07:50.632Z
SHA-256 of the archived text
9a93eca70048dbd6f6fa88404bc1642d03373003e4139268eca01916159b5ba1
Stable URL of this page
https://metraipolis.com/documento/dc_ddc457922cb3

How to cite

Lenalidomide ameliorates cognitive impairment via putative AChE inhibition: an in silico and in vivo study in a scopolamine-induced cognitive impairment model — Europe PMC PMID:42177211 — Europe PMC (en), https://europepmc.org/article/MED/42177211 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddc457922cb3 (Metraipolis archive dc_ddc457922cb3, sha256 9a93eca70048dbd6f6fa88404bc1642d03373003e4139268eca01916159b5ba1)
BibTeX
@misc{dcddc457922cb3,
  title = {Lenalidomide ameliorates cognitive impairment via putative AChE inhibition: an in silico and in vivo study in a scopolamine-induced cognitive impairment model — Europe PMC PMID:42177211},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42177211},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddc457922cb3; sha256 9a93eca70048dbd6f6fa88404bc1642d03373003e4139268eca01916159b5ba1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42177211. Agents can read the archived copy with the MCP tool read_document.